Altered subcellular distribution of c-Abl in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 409-422

  Jing, Zheng ^a,b   Caltagarone, John ^a   Bowser, Robert ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Amyloid ; C Abl; Granulovacuolar degeneration bodies; Tau

Indexed keywords

ABELSON KINASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 67849130954     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1062     Document Type: Article

References (38)

1. Ozanne B, Wheeler T, Zack J, Smith G, Dale B (1982) Transforming gene of a human leukaemia cell is unrelated to the expressed tumour virus related gene of the cell. Nature 299, 744-747.
2. Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D (1986) Alternative 5' exons in c-abl mRNA. Cell 44, 577-586.
3. Van Etten RA, Jackson P, Baltimore D (1989) The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58, 669-678.
4. Wen ST, Jackson PK, Van Etten RA (1996) The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J 15, 1583-1595.
5. Kipreos ET, Wang JY (1992) Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256, 382-385.
6. Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT, Janmey PA (1994) The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J Cell Biol 124, 325-340.
7. Brasher BB, Van Etten RA (2000) c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J Biol Chem 275, 35631-35637.
8. Pluk H, Dorey K, Superti-Furga G (2002) Autoinhibition of c-Abl. Cell 108, 247-259.
9. McWhirter JR, Wang JY (1993) An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12, 1533-1546.
10. Van Etten RA (2003) c-Abl regulation: a tail of two lipids. Curr Biol 13, R608-610.
11. Dorey K, Engen JR, Kretzschmar J, Wilm M, Neubauer G, Schindler T, Superti-Furga G (2001) Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase. Oncogene 20, 8075-8084.
12. WoodringPJ,HunterT,WangJY(2003)RegulationofF-actin- dependent processes by the Abl family of tyrosine kinases. J Cell Sci 116, 2613-2626.
13. Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol 7, 278-285.
14. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai LH (2000) Cables links Cdk5 and c-Abl and facilitates Cdk5 ty- rosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26, 633-646.
15. Leyssen M, Ayaz D, Hebert SS, Reeve S, De Strooper B, Hassan BA (2005) Amyloid precursor protein promotes post- developmental neurite arborization in the Drosophila brain. EMBO J 24, 2944-2955.
16. Morishima-Kawashima M, Ihara Y (2002) Alzheimer's disease: beta-Amyloid protein and tau. J Neurosci Res 70, 392401.
17. Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science 278, 412-419.
18. Alvarez AR, Sandoval PC, Leal NR, Castro PU, Kosik KS (2004) Activation of the neuronal c-Abl tyrosine kinase by amyloid-beta-peptide and reactive oxygen species. Neurobiol Dis 17, 326-336.
19. Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH (2005) Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci 25, 6584-6593.
20. Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J (2006) Therapeutic approaches to Alzheimer's disease. Brain 129, 2840-2855.
21. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brown-lee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
22. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56, 1095-1097.
23. Reynolds FH, Jr., Oroszlan S, Stephenson JR (1982) Abelson murine leukemia virus P120: identification and characterization of tyrosine phosphorylation sites. J Virol 44, 1097-1101.
24. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM (1999) c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev 13, 2400-2411.
25. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, Watanabe M (1991) Reexamination of granulovacuolar degeneration. Acta Neuropathol (Berl) 82, 340-345.
26. Tomlinson BE, Kitchener D (1972) Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol 106, 165-185.
27. Smith JM, Mayer BJ (2002) Abl: mechanisms of regulation and activation. Front Biosci 7, d31-42.
28. Bondareff W, Wischik CM, Novak M, Roth M (1991) Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 139, 641-647.
29. Lee G (2005) Tau and src family tyrosine kinases. Biochim Biophys Acta 1739, 323-330.
30. Echarri A, Pendergast AM (2001) Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr Biol 11, 1759-1765.
31. Zhu X, Lee HG, Raina AK, Perry G, Smith MA (2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11, 270-281.
32. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76, 435-441.
33. Lagalwar S, Berry RW, Binder LI (2007) Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies. Acta Neuropathol (Berl) 113, 63-73.
34. Barila D, Mangano R, Gonfloni S, Kretzschmar J, Moro M, Bohmann D, Superti-Furga G (2000) A nuclear tyrosine phos- phorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK. EMBO J 19, 273-281.
35. Van Etten RA (1999) Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol 9, 179-186.
36. Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, MiczekKA, Baltimore D (1998) Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272.
37. Caltagarone J, Jing Z, Bowser R (2007) Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. Biochim Biophys Acta 1772, 438-445.
38. Thakur A, Wang X, Siedlak SL, Perry G, Smith MA, Zhu X (2007) c-Jun phosphorylation in Alzheimer disease, J NeurosciRes 85, 1668-1673.